As a matter of fact, this study focused specifically on elderly patients, who are characterized by an increased risk of carrying ARCH/CHIP lesions, possibly serving as a predictive biomarker for t-MN development in this specific setting. The gene discussed is STUB1; the disease is therapy-related myeloid neoplasm.